These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 31300965)
21. Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement. Muchow M; Maincent P; Müller RH; Keck CM Drug Dev Ind Pharm; 2011 Jan; 37(1):8-14. PubMed ID: 21138344 [TBL] [Abstract][Full Text] [Related]
22. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation. Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655 [TBL] [Abstract][Full Text] [Related]
23. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Nagaich U; Gulati N Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979 [TBL] [Abstract][Full Text] [Related]
24. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic. Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859 [TBL] [Abstract][Full Text] [Related]
25. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers. Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416 [TBL] [Abstract][Full Text] [Related]
26. Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers. Chu Y; Li D; Luo YF; He XJ; Jiang MY Molecules; 2014 Feb; 19(2):2445-57. PubMed ID: 24566313 [TBL] [Abstract][Full Text] [Related]
29. [Effect of ginsenoside Rg_3 nanostructured lipid carrier modified by pullulan on promoting absorption and its anti-tumor evaluation in vitro]. Qing Y; Ning C; Dao-Biao C; Xin J Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(21):5184-5192. PubMed ID: 33350234 [TBL] [Abstract][Full Text] [Related]
30. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam. Khurana S; Jain NK; Bedi PM Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071 [TBL] [Abstract][Full Text] [Related]
31. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin. Sütő B; Berkó S; Kozma G; Kukovecz Á; Budai-Szűcs M; Erős G; Kemény L; Sztojkov-Ivanov A; Gáspár R; Csányi E Int J Nanomedicine; 2016; 11():1201-12. PubMed ID: 27099487 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003 [TBL] [Abstract][Full Text] [Related]
33. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers. Yang CR; Zhao XL; Hu HY; Li KX; Sun X; Li L; Chen DW Chem Pharm Bull (Tokyo); 2010 May; 58(5):656-61. PubMed ID: 20460792 [TBL] [Abstract][Full Text] [Related]
35. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation. Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497 [TBL] [Abstract][Full Text] [Related]
36. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release. Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657 [TBL] [Abstract][Full Text] [Related]
37. A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease. Beloqui A; Memvanga PB; Coco R; Reimondez-Troitiño S; Alhouayek M; Muccioli GG; Alonso MJ; Csaba N; de la Fuente M; Préat V Colloids Surf B Biointerfaces; 2016 Jul; 143():327-335. PubMed ID: 27022873 [TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of nanostructured lipid carriers as drug delivery system: Influence of liquid lipid types on loading and cytotoxicity. Saedi A; Rostamizadeh K; Parsa M; Dalali N; Ahmadi N Chem Phys Lipids; 2018 Nov; 216():65-72. PubMed ID: 30219661 [TBL] [Abstract][Full Text] [Related]
39. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application. Nnamani PO; Hansen S; Windbergs M; Lehr CM Int J Pharm; 2014 Dec; 477(1-2):208-17. PubMed ID: 25290810 [TBL] [Abstract][Full Text] [Related]